Literature DB >> 33532605

Prevalence of prediabetes, and diabetes in Chandigarh and Panchkula region based on glycated haemoglobin and Indian diabetes risk score.

Saurabh Kumar1, Akshay Anand1, Raghuram Nagarathna2, Navneet Kaur1,3, Madhava Sai Sivapuram4, Viraaj Pannu5, Deepak Kumar Pal1, Neeru Malik6, Amit Kumar Singh2, Hongasandra Ramarao Nagendra2.   

Abstract

There is a rapid increase in the prevalence of diabetes in India. We wanted to review the status of prediabetes and diabetes in the combined population of Chandigarh and Panchkula region based on both Indian Diabetes Risk Score (IDRS) and Glycated Haemoglobin (HbA1c). A total of 1215 subjects were recruited during the screening process, out of which 444 i subjects have been analysed for the current study on the basis of high risk for IDRS (≥60) and their known diabetes status. This study included 431 subjects having high risk for IDRS (≥60) and 13 known subjects with diabetes (IDRS < 60) which were further analysed for biochemical and anthropometric parameters. The prevalence of diabetes was found to be 12.67% and prediabetes 11.69% in the combined population of Chandigarh and Panchkula. There was an increased level of fasting blood glucose (183.12 ± 68.61), postprandial blood glucose (262.57 ± 96.92), triglyceride (193.84 ± 119.88), very low-density lipoprotein (VLDL) (34.87 ± 15.42) and High Density Lipoprotein(HDL) (4.61 ± 1.39) in the said diabetes population. Mean HDL was found to be decreased in subjects having diabetes. Glucose-induced lipid intolerance study revealed significant alteration in triglyceride, HDL and VLDL. The study has revealed that high prevalence of diabetes in the sampled population when compared with the national average of 8.8%.
© 2020 The Authors. Endocrinology, Diabetes & Metabolism published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Indian diabetes risk score; blood glucose; diabetes; glycated haemoglobin

Year:  2020        PMID: 33532605      PMCID: PMC7831224          DOI: 10.1002/edm2.162

Source DB:  PubMed          Journal:  Endocrinol Diabetes Metab        ISSN: 2398-9238


  25 in total

1.  Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial.

Authors:  Curt L Rohlfing; Hsiao-Mei Wiedmeyer; Randie R Little; Jack D England; Alethea Tennill; David E Goldstein
Journal:  Diabetes Care       Date:  2002-02       Impact factor: 19.112

Review 2.  Diabetes Care in India.

Authors:  Shashank R Joshi
Journal:  Ann Glob Health       Date:  2015 Nov-Dec       Impact factor: 2.462

3.  Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).

Authors:  Celine Droumaguet; Beverley Balkau; Dominique Simon; Emile Caces; Jean Tichet; Marie Aline Charles; Eveline Eschwege
Journal:  Diabetes Care       Date:  2006-07       Impact factor: 19.112

Review 4.  The role of hemoglobin A1c in the assessment of diabetes and cardiovascular risk.

Authors:  Courtney Nagel Sandler; Marie E McDonnell
Journal:  Cleve Clin J Med       Date:  2016-05       Impact factor: 2.321

Review 5.  HDL dysfunction in diabetes: causes and possible treatments.

Authors:  Dan Farbstein; Andrew P Levy
Journal:  Expert Rev Cardiovasc Ther       Date:  2012-03

6.  Prevalence and risk factors of diabetes in a community-based study in North India: the Chandigarh Urban Diabetes Study (CUDS).

Authors:  P Ravikumar; A Bhansali; M Ravikiran; S Bhansali; R Walia; G Shanmugasundar; J S Thakur; S Kumar Bhadada; P Dutta
Journal:  Diabetes Metab       Date:  2010-12-30       Impact factor: 6.041

7.  Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemia.

Authors:  H A Khan; S H Sobki; S A Khan
Journal:  Clin Exp Med       Date:  2007-03       Impact factor: 3.984

8.  A1C and diabetes diagnosis: The Rancho Bernardo Study.

Authors:  Caroline K Kramer; Maria Rosario G Araneta; Elizabeth Barrett-Connor
Journal:  Diabetes Care       Date:  2009-10-16       Impact factor: 19.112

9.  Methodology of Niyantrita Madhumeha Bharata Abhiyaan-2017, a Nationwide Multicentric Trial on the Effect of a Validated Culturally Acceptable Lifestyle Intervention for Primary Prevention of Diabetes: Part 2.

Authors:  R Nagarathna; S K Rajesh; S Amit; S Patil; A Anand; H R Nagendra
Journal:  Int J Yoga       Date:  2019 Sep-Dec

10.  Niyantrita Madhumeha Bharata 2017, Methodology for a Nationwide Diabetes Prevalence Estimate: Part 1.

Authors:  H R Nagendra; R Nagarathna; S K Rajesh; S Amit; S Telles; A Hankey
Journal:  Int J Yoga       Date:  2019 Sep-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.